A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Ting‐Chao Chou, Paul Talalay · Advances in Enzyme Regulation · 1984 · 7.1K citations

Pharmacological Study, Pharmacoepidemiology, Quantitative Analysis +10

Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27

Harry D. Bear, Stewart Anderson, Roy E. Smith et al. · Journal of Clinical Oncology · 2006 · 943 citations · Full text

Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)

George W. Sledge, Donna Neuberg, Patricia Bernardo et al. · Journal of Clinical Oncology · 2003 · 701 citations

Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues

Youichiro Noguchi, Jun Wu, Ruth Duncan et al. · Japanese Journal of Cancer Research · 1998 · 460 citations · Full text

A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System

Ho Lun Wong, Reina Bendayan, Andrew M. Rauth et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 348 citations